Charles Sherwood
Vermogen: 67 477 $ op 30-06-2026
Vermogen: 67 477 $ op 30-06-2026
Charles Sherwood is currently Director at Vedanta Biosciences, Inc. and COO, Secretary & General Counsel at PureTech Health Plc since 2021.
Formerly, Mr. Sherwood was Vice President-Legal Counsel at Anika Therapeutics, Inc. Education includes graduate studies at Vanderbilt University and undergraduate studies at Middlebury College.
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
PURETECH HEALTH PLC 0,02% | 14-07-2026 | 37.001 ( 0,02% ) | 67 477 $ | 30-06-2026 |
| Bedrijven | Functie | Begin |
|---|---|---|
| PURETECH HEALTH PLC | Operationeel Directeur | 01-08-2021 |
Vedanta Biosciences, Inc.
Vedanta Biosciences, Inc. BiotechnologyHealth Technology Develops microbial therapies that address the human immune system | Directeur/Bestuurslid | - |
| Bedrijven | Functie | Einde |
|---|---|---|
| ANIKA THERAPEUTICS, INC. | Algemeen Adviseur | 01-08-2021 |
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
| Bedrijven in privébezit | 5 |
|---|---|
Anika Therapeutics, Inc.
Anika Therapeutics, Inc. Medical SpecialtiesHealth Technology Develops, manufactures and commercializes therapeutic products for tissue protection, healing and repair | Health Technology |
Vanderbilt University
Vanderbilt University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Middlebury College
Middlebury College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Vedanta Biosciences, Inc.
Vedanta Biosciences, Inc. BiotechnologyHealth Technology Develops microbial therapies that address the human immune system | Health Technology |
PureTech Health Plc
PureTech Health Plc BiotechnologyHealth Technology Engages in the development of treatment programs for obesity, cognitive disorders, baldness, depression, allergy and autoimmune | Health Technology |
Kies jouw editie
Alle financiële informatie op nationaal niveau